Comparison of ADAPT, FIB4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR Screening Population
出版年份 2021 全文链接
标题
Comparison of ADAPT, FIB4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR Screening Population
作者
关键词
PRO-C3, ADAPT, CENTAUR, extracellular matrix, type III collagen, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, serological markers, neoepitope
出版物
JOURNAL OF HEPATOLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-08-27
DOI
10.1016/j.jhep.2021.08.016
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients
- (2020) Mohammed Eslam et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes
- (2019) Fernando Bril et al. DIABETES CARE
- Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis
- (2018) M. J. Nielsen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- ADAPT: An algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis
- (2018) Samuel J. Daniels et al. HEPATOLOGY
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
- (2018) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- The future of diagnosing NASH - could a simple blood test be the key?
- (2017) Sven Francque et al. Expert Review of Gastroenterology & Hepatology
- Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
- (2016) Scott Friedman et al. Contemporary Clinical Trials
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?
- (2016) Christopher D. Byrne et al. DIABETOLOGIA
- Novel insights into the function and dynamics of extracellular matrix in liver fibrosis
- (2015) Morten A. Karsdal et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients
- (2015) Mette J. Nielsen et al. PLoS One
- Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
- (2015) D. J. Leeming et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers
- (2014) Diana J. Leeming et al. AIDS
- Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar
- (2014) M. A. Karsdal et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C
- (2014) Mette J. Nielsen et al. LIVER INTERNATIONAL
- Non-Invasive markers for hepatic fibrosis
- (2011) Ancha Baranova et al. BMC GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started